Can CAH Sustain Growth on Booming Pharmaceutical & Specialty Segment?

Cardinal Health's CAH Pharmaceutical & Specialty Solutions segment continues to be the primary engine of enterprise growth, delivering another standout quarter in the third quarter of fiscal 2026. Segment revenues climbed 19% to approximately $61 billion, while segment profit increased 29%, underscoring the segment's growing importance to Cardinal Health's earnings profile.